整合代谢组学与微生物组揭示速效救心丸治疗稳定型冠心病的配伍机制
本研究以代谢组学评估稳定型冠心病(SCAD)患者服用速效救心丸前后的血清代谢谱,并用代谢组学与16S rRNA测序探讨川芎与冰片配伍机制。结果显示速效救心丸显著调节患者脂质代谢,尤其影响甘油磷脂与脂肪酰类;冰片可剂量依赖性增加川芎活性成分入血,并与A. muciniphila富集及宿主脂质代谢调节相关。
要点
- 速效救心丸可显著调节SCAD患者脂质代谢,重点涉及甘油磷脂与脂肪酰类。
- 冰片剂量依赖性促进川芎活性成分吸收入血,并富集A. muciniphila。
- A. muciniphila与川芎联用可促进川芎活性成分吸收并影响宿主脂质代谢。
核心结论
- 速效救心丸治疗SCAD与脂质代谢改善相关,冰片通过剂量依赖性富集A. muciniphila调节宿主脂质代谢并促进川芎活性成分入血。
研究设计与样本
- 采用代谢组学评估SCAD患者服用速效救心丸前后的血清代谢谱。
- 用代谢组学与16S rRNA测序在小鼠中探讨川芎与冰片多组分配伍机制。
主要发现
- 速效救心丸显著调节SCAD患者脂质代谢,尤其影响甘油磷脂与脂肪酰类。
- 小鼠中冰片剂量依赖性增加川芎活性成分吸收入血。
- 该效应与A. muciniphila剂量依赖性富集及其调节宿主脂质代谢(甘油磷脂与脂肪酰类)相关。
- A. muciniphila与川芎联用显著促进川芎活性成分入血并影响宿主脂质代谢。
临床怎么用
- 为速效救心丸中川芎与冰片配伍的合理性提供代谢与微生物组层面的解释。
- 提示冰片可能通过肠道菌群途径影响活血成分吸收,可供中西医结合用药分析参考。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The Suxiao Jiuxin pill (SJP) is a Chinese patent medicine that is used for the treatment of stable coronary artery disease (SCAD). However, the compatibility mechanism of SJP in treating of SCAD is still unclear. This study aimed to elucidate the serum metabolic profiles of patients with SCAD treated with SJP and to decipher the compatibility mechanism of its effective components, Chuanxiong Rhizoma and borneol. METHODS: We employed metabolomics to assess the serum metabolic profiles of SCAD patients before and after treatment with SJP through metabolomics. Additionally, the compatibility mechanism of the multicomponent pairing of Chuanxiong Rhizoma and borneol was explored using metabolomics and 16S rRNA sequencing. RESULTS: Our findings indicate that SJP significantly modulates lipid metabolism in SCAD patients, with particular impacts on glycerophospholipids and fatty acyls. Coadministration of Chuanxiong Rhizoma and borneol in mice demonstrated that borneol increases the absorption of the active components of Chuanxiong Rhizoma into the blood in a dose-dependent manner. This effect correlated with the dose-dependent enrichment of A. muciniphila and its role in modulating host lipid metabolism (glycerophospholipids and fatty acyls). Moreover, the combination of A. muciniphila and Chuanxiong Rhizoma also significantly promoted the absorption of the active components of Chuanxiong Rhizoma into the blood and affected host lipid metabolism (glycerophospholipids and fatty acyls). CONCLUSION: This study is the first to demonstrate a link between SJP treatment in SCAD patients and improved lipid metabolism. Borneol enriches A. muciniphila in a dose-dependent manner, thereby regulating host lipid metabolism and facilitating the absorption of the active components of Chuanxiong Rhizoma into the blood.
引用
- Le W, Liao J, Zhang Y, et al. Integrated metabolomics and the microbiome reveal the compatibility mechanism of the Suxiao Jiuxin pill in the treatment of stable coronary artery disease. Chin Med. 2025. PMID: 40890831. doi:10.1186/s13020-025-01198-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。